Molecular detection of CF lung pathogens: current status and future potential

Area of Science:

• Microbiology
• Molecular Diagnostics
• Infectious Diseases

Background:

• Current cystic fibrosis (CF) microbiology services face challenges due to the complex polymicrobial nature of airway infections.
• Standard diagnostic practices may fail to detect fastidious or slow-growing microbes and misidentify emerging pathogens.

Purpose of the Study:

• To review existing molecular diagnostic tests for their suitability in CF microbiology.
• To identify key requirements for developing effective molecular assays focused on CF pathogens.

Main Methods:

• Literature review of molecular diagnostic technologies.
• Analysis of current and future needs in CF microbiology diagnostics.
• Discussion of assay characteristics including speed, throughput, multiplexing, data interpretation, and antimicrobial susceptibility testing.

Main Results:

• Molecular diagnostic tests, based on nucleic acid detection, show potential to overcome limitations of traditional culture-based methods.
• Culture-independent molecular technologies offer high target specificity for identifying diverse CF pathogens.

Conclusions:

• Molecular diagnostics are poised to significantly benefit CF microbiology services.
• Future CF microbiology assays should consider speed, throughput, multiplex pathogen detection, data interpretation, and antimicrobial susceptibility testing for comprehensive diagnosis.